Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Healthcare
Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Cardiol Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(79)
•••
Post by Youhillmanon Oct 19, 2020 9:45am
144 Views
Post# 31738240

More good news...Cortalex now available at Shoppers...

More good news...Cortalex now available at Shoppers...

Cortalex™ 100 CBD Oil is now available at Medical Cannabis by Shoppers. For more information please visit: Cortalex.com. 
In order to purchase Cortalex™, you will need to have a completed medical document signed by your Healthcare Practitioner. You can download a medical document form here. Alternatively, you can schedule a free, private video consult with a HelloMD healthcare practitioner today.

Cortalex™ is a pharmaceutically produced CBD Oil, free of THC (<10 ppm). This means you can receive the potential therapeutic benefits of CBD without the intoxicating effects associated with THC.
Medical Cannabis by Shoppers is the exclusive distributor for Cortalex™ in Canada. For more information, please contact Shoppers Customer Care
at 1-844-633-2627.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities